BioCardia, Inc.
BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) PRECURSOR CELLS FOR THERAPEUTIC APPLICATIONS

Last updated:

Abstract:

The present disclosure provides use of neurokinin 1 receptor (NK1R) as a marker for identifying and/or isolating multipotential cells. The present disclosure provides cell populations enriched by methods of the present disclosure and therapeutic uses of these cells and agents derived from these cells.

Status:
Application
Type:

Utility

Filling date:

26 Sep 2019

Issue date:

2 Apr 2020